Use of hif prolyl hydroxylase inhibitors for treating neurological disorders
CA 3094774 A1 · Owner: Fibrogen, Inc. · Inventors: Lin, Al Y.; Wang, Qingjian; Flippin, Lee A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compounds of formula (I) that inhibit hypoxia inducible factor, (HIF) prolyl hydroxylase activity. Compounds are also provided for treating or preventing a, neurological disorder in a subject. Uses of the compounds of formula (I) are also included. R1, R2, Yv Q-R4, (I), Y X, Date Recue/Date Received 2020-09-30
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 6, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 6, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 6, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.